Trials / Conditions / ESRD (End Stage Renal Disease)

ESRD (End Stage Renal Disease)

13 registered clinical trials studyying ESRD (End Stage Renal Disease) — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD NCT07224763	United Therapeutics	Phase 1 / Phase 2
Recruiting	Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD NCT06878560	United Therapeutics	Phase 1 / Phase 2
Completed	Fluid Status of ESRD Patients Undergoing Dialysis NCT07217470	HemoCept Inc.	—
Not Yet Recruiting	Copper to Zinc Ratio in End Stage Renal Disease Patients Outcome NCT07109778	Minia University	—
Not Yet Recruiting	The Effects of a Dialysis-Specific Formula Rich in Branched-Chain Amino Acids, Omega-3, and Dietary Fiber on N NCT07060040	Buddhist Tzu Chi General Hospital	N/A
Recruiting	A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China NCT06933472	Alebund Pharmaceuticals	Phase 3
Withdrawn	Improving Access to Renal Transplantation for Underserved Black Communities NCT06707038	Northwestern University	N/A
Completed	Fluid Status of Dialysis Subjects NCT07217041	HemoCept Inc.	—
Completed	AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia NCT07030595	Alebund Pharmaceuticals	Phase 3
Completed	Exercise Training Versus Ropinirole in Treating Restless Legs Syndrome Among Hemodialysis Patients NCT06468371	Lahore General Hospital	N/A
Completed	Predictive Tools for the Presence of Significant Coronary Artery Disease Requiring Intervention in Chronic Hem NCT06661941	Chulalongkorn University	—
Completed	A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunc NCT02902679	Bristol-Myers Squibb	Phase 1
Completed	Research and Validation of a Big Data-Driven Intelligent Decision-Making System for Hemodialysis NCT07466329	Huashan Hospital	—